Stockreport

General Proximity Announces Multi-Target Collaboration with Daiichi Sankyo to Discover and Advance Novel Oncology Therapeutics Using OmniTAC™ Platform [Yahoo! Finance]

DAIICHI SANKYO S/ADR  (DSNKY) 
PDF - Induced proximity medicines, powered by the OmniTAC ™ platform, enable precise modulation of disease-driving and traditionally undruggable proteins. - General Proxi [Read more]